Growth hormone as a neuronal rescue factor during recovery from CNS injury
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
There is growing evidence to suggest that growth hormone plays a role in the growth and development of the CNS. Specifically, growth hormone has been implicated in promoting brain growth, myelination, neuronal arborisation, glial differentiation and cognitive function. Here we investigate if growth hormone has a role in the recovery from an unilateral hypoxic-ischaemic brain injury. Using moderate (15 min hypoxia) and severe (60 min hypoxia) models of hypoxic-ischaemia in juvenile rats and standard immunohistochemical techniques, we found intense growth hormone-like immunoreactivity present within regions of cell loss by 3 days (P<0.05). Growth hormone-like immunoreactivity was observed on injured neurones, myelinated axons, glial cells within and surrounding infarcted tissue and on the choroid plexus plus ependymal cells within the injured hemisphere. The pattern of immunoreactivity suggests that (a) growth hormone (or a growth hormone-like substance) is transported via the cerebrospinal fluid and (b) that growth hormone (or a growth hormone-like substance) is acting in a neurotrophic manner specifically targeted to injured neurones and glia. To test this hypothesis we treated a moderate hypoxic-ischaemic brain injury with 20 microg of rat growth hormone by intracerebroventricular infusion starting 2 h after injury (n=12/group). After 3 days the animals were killed and the extent of neuronal loss quantified. Growth hormone treatment reduced neuronal loss in the frontoparietal cortex (P<0.001), hippocampus (P<0.01) and dorsolateral thalamus (P<0.01) but not in the striatum. This spatial distribution of the neuroprotection conveyed by growth hormone correlates with the spatial distribution of the constitutive neural growth hormone receptor, but not with the neuroprotection offered by insulin-like growth factor-I treatment in this model. These results suggest that some of the neuroprotective effects of growth hormone are mediated directly through the growth hormone receptor and do not involve insulin-like growth factor-I induction.In summary, we have found that a growth hormone-like factor increased in the brain in the days after injury. In addition, treatment with growth hormone soon after an hypoxic-ischaemic injury reduced the extent of neuronal loss. These results further suggest that a neural growth hormone axis is activated during recovery from injury and that this may act to restrict the extent of neuronal death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“most of the pituitary hormones have been shown to have important cerebral effects that impact not only brain development, but also allow normal brain function and are integral for effective brain repair and recovery.”
From Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury (2012) · cites this paper as [51]
In the citing paper
“it is now clear that there are both GH and insulinlike growth factor (IGF-1) receptors widely present in the brain.”
From Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury (2012) · cites this paper as [51]
In the citing paper
“GH has been shown to be directly involved in vascular reactivity, vascular tone and CNS repair processes after hypoxic injury”
From Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury (2012) · cites this paper as [51]
In the citing paper
“IGF-1 appears to be an important factor in myelination, re-myelination, prevention of demyelination and protection of oligodendrocytes from tumor necrosis factor-α induced apoptosis [47–56].”
From Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury (2012) · cites this paper as [51]
In the citing paper
“These hormones are also pivotal in maintaining the integrity and function of the cardiovascular and cerebrovascular systems (Bickel et al., 2023; Napoli et al., 2003; Scheepens et al., 2001; Silha et al., 2005; Tarantini et al., 2021a, 2021b; Norling et al., 2020; Kiss et al., 2022; Wagner et al., 2010).”
From Acute neuroendocrine changes after traumatic brain injury (2024) · cites this paper as Scheepens et al., 2001
Citations
Cites
Leptin enters the brain by a saturable system independent of insulin
Banks, W. A., Kastin, A. J., Huang, W., Jaspan, J. B., & Maness, L. M. (1996) · Peptides · doi:10.1016/0196-9781(96)00025-3 · Cited by 1,224
Beck, K. D., Powell-Braxtont, L., Widmer, H.-R., Valverde, J., & Hefti, F. (1995) · Neuron · doi:10.1016/0896-6273(95)90216-3 · Cited by 636
Brain Injury Causes a Time-Dependent Increase in Neuronotrophic Activity at the Lesion Site
Nieto-Sampedro, M., Lewis, E. R., Cotman, C. W., Manthorpe, M., Skaper, S. D., Barbin, G., Longo, F. M., & Varon, S. (1982) · Science · doi:10.1126/science.7100931 · Cited by 475
Bondy, C., Werner, H., Roberts, C. T., & LeRoith, D. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90193-6 · Cited by 372
Radioimmunoassays for IGFs and IGFBPs.
Blum, W. F. P., & Breier, B. H. (1994) · PubMed · Cited by 362
Self-citationBeilharz, E. J., Williams, C. E., Dragunow, M., Sirimanne, E. S., & Gluckman, P. D. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00217-3 · Cited by 356
Self-citationABE, H., MOLITCH, M. E., VAN WYK, J. J., & UNDERWOOD, L. E. (1983) · Endocrinology · doi:10.1210/endo-113-4-1319 · Cited by 281
Minor tranquillizers, stress and central catecholamine neurons
Corrodi, H., Fuxe, K., Lidbrink, P., & Olson, L. (1971) · Brain Research · doi:10.1016/0006-8993(71)90413-6 · Cited by 277
Cytokines and Metabolic Dysfunction After Severe Head Injury
OTT, L., McCLAIN, C. J., GILLESPIE, M., & YOUNG, B. (1994) · Journal of Neurotrauma · doi:10.1089/neu.1994.11.447 · Cited by 266
A Receptor-Mediated Mechanism for the Transport of Prolactin from Blood to Cerebrospinal Fluid*
WALSH, R. J., SLABY, F. J., & POSNER, B. I. (1987) · Endocrinology · doi:10.1210/endo-120-5-1846 · Cited by 250
Research works printed but not linked: 2
- Chen, 1997, Growth hormone, insulin-like growth factor I, and motoneuron size, J. Neurobiol., 32, 202, 10.1002/(SICI)1097-4695(199702)32:2<202::AID-NEU5>3.0.CO;2-C · DOI · Paper page
- Haeffner, 1999, Growth hormone prevents human monocytic cells from Fas-mediated apoptosis by up-regulating Bcl-2 expression, Eur. J. Immunol., 29, 334, 10.1002/(SICI)1521-4141(199901)29:01<334::AID-IMMU334>3.0.CO;2-S · DOI
Cited by
The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain
Russo, V. C., Gluckman, P. D., Feldman, E. L., & Werther, G. A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0024 · Cited by 492
Self-citationÅberg, N. D., Brywe, K. G., & Isgaard, J. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.22 · Cited by 387
Occurrence of pituitary dysfunction following traumatic brain injury
Bondanelli, M., De Marinis, L., Ambrosio, M. R., Monesi, M., Valle, D., Zatelli, M. C., Fusco, A., Bianchi, A., Farneti, M., & Degli, E. C. I. (2004) · Journal of Neurotrauma · doi:10.1089/0897715041269713 · Cited by 322
“Moreover growing evidence indicates that GH plays an important role in the recovery of the central nervous system from brain injury (Scheepens et al., 2000, 2001).”
Stein, T. D., & Johnson, J. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07380.2002 · Cited by 288
“Growth hormone receptor is expressed on multiple cell types throughout the brain, and intraventricular injection of GH has reduced neuronal loss in the frontoparietal cortex and hippocampus after an ischemic brain injury (Scheepens et al., 2001).”
BackgroundThe structure of the choroid plexus and the physiology of the choroid plexus epithelium
REDZIC, Z., & SEGAL, M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.005 · Cited by 257
Metadata
- Authors
- Scheepens, A., Sirimanne, E. S., Breier, B. H., Clark, R. G., Gluckman, P. D., & Williams, C. E.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Williams, C.E
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 104
- Issue
- 3
- Pages
- 677-687
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2077462719
- Cited by
- 174
- References
- 43
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 10 · 2017: 3 · 2016: 3 · 2015: 5 · 2014: 7 · 2013: 5 · 2012: 11
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- growth hormone, neuroprotection, hypoxic-ischemic brain injury, neuronal loss, growth hormone receptor, insulin-like growth factor I, cerebrospinal fluid, choroid plexus, ependymal cells, intracerebroventricular infusion, brain injury recovery, young rats
- MeSH terms
- Animals, Brain, Brain Injuries, Carrier Proteins, Cell Count, Cell Survival, Female, Immunohistochemistry, Male, Nerve Growth Factors, Neuroglia, Neurons, Recombinant Proteins, Growth Hormone, Rats, Wistar, Apoptosis, Neuroprotective Agents, Recovery of Function, Hypoxia-Ischemia, Brain, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Growth hormone as a neuronal rescue factor during recovery from CNS injury. https://app.cochat.ai/papers/10.1016/s0306-4522(01)00109-9
- The paper
- Scheepens, A., Sirimanne, E. S., Breier, B. H., Clark, R. G., Gluckman, P. D., & Williams, C. E. (2001). Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience. https://doi.org/10.1016/s0306-4522(01)00109-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.